TWO New Arrival Members Strengthen Bioperfectus Total PCR Solution

Company news
2022-04-22

Shanghai, China--Today, we Bioperfectus are proud to launch two new products: Bacteria DNA Extraction Kit and Dengue Virus Real Time PCR Kit. They will join Bioperfectus Total PCR Solution, enrich our extraction sample types and provide more PCR choices for clinical laboratories.

 

 

Bacteria DNA Extraction Kit (Magnetic Bead Method)

Features

  •  Suitable for gram-positive and gram-negative bacteria
  •  Easy-to-use: prepacked design promotes the efficiency of the extraction process
  •   High yield: 1~20 μg DNA obtained from 0.5 × 109-5.0 × 109 bacteria
  •   Safe and harmless: without the use of toxic reagents, e.g., benzene, chloroform
  •  Compatible with Bioperfectus SSNP, SMPE, SAW extractors

 

 

Dengue Virus Real Time PCR Kit

Features

  •  Reliable: Detection of Dengue virus, verified with DENV1/2/3/4 serotypes
  •  Accurate: Internal control ensures the whole process’s reliability
  •  Efficient: 96 tests in 110 minutes (on an instrument)
  •  Extensive: Compatible with Bioperfectus STC-96A, STC-96A Plus, and other mainstream instruments

 

Bioperfectus Total PCR solution will provide products, including reagents and instruments.

 

With the new member of the Bacteria DNA Extraction Kit, the extraction procedure for samples containing all kinds of gram-positive/negative bacteria is available in our extractors. With different throughputs of extractors, solutions will cover the clinical demands from small to ultra-high sample sizes.

 

Dengue Virus Real Time PCR Kit will enrich the vector-borne PCR solution and provide flexible PCR products for clinical decisions. It will detect Dengue Virus no matter which DENV serotypes and could be a cost-effective screen tool for Dengue fever.

 

Welcome to contact us at info@bioperfectus.com for more information about the kits, instruments, and how to use them.

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14